超声引导下微波消融对复发性肝癌长期疗效的影响因素研究

摘要/Abstract

摘要： 目的探讨超声引导下微波消融对复发性肝癌长期疗效的影响因素。方法收集2019年9月—2021年9月濮阳市中医医院80例复发性肝癌患者的资料进行回顾性分析,术后随访1年,根据术后1年生存情况将80例复发性肝癌患者分为预后不良组(死亡,22例)及预后良好组(存活,58例)。比较两组临床资料,检测血清甲胎蛋白(AFP)、白蛋白(Alb)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)水平;通过多因素logistic回归性分析明确影响复发性肝癌患者超声引导下微波消融治疗后长期疗效的因素。结果预后不良组Child-Pugh分级B级、多发病灶、病灶直径≥3 cm、AFP≥100 ng/mL的患者分别为8例(36.36%)、11例(50.00%)、10例(45.45%)、9例(40.91%),与预后良好组8例(13.79%)、12例(20.69%)、13例(22.41%)、10例(17.24%)相比,差异有统计学意义(P<0.05);经多因素logistic回归性分析,Child-Pugh分级B级、多发病灶、病灶直径≥3 cm、AFP≥100 ng/mL是复发性肝癌患者超声引导下微波消融治疗后预后不良的危险因素(P<0.05)。结论对于Child-Pugh分级A级、单发病灶、病灶直径＜3 cm、AFP<100 ng/mL的复发性肝癌患者来说,超声引导下微波消融治疗的长期疗效更好。

关键词: 超声引导下微波消融, 复发性肝癌, 疗效, 影响因素

Abstract: Objective To investigate the influence factors of ultrasound-guided microwave ablation on the long-term treatment outcomes of recurrent liver cancer. Methods We collected data from 80 patients with recurrent liver cancer treated at our hospital from September 2019 to September 2021 and conducted a retrospective analysis. The patients were divided into a poor prognosis group (22 deaths) and a good prognosis group (55 survivals) based on their 1-year postoperative survival. Clinical data were compared between the two groups, including serum levels of alpha-fetoprotein (AFP), albumin (Alb), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Multiple Logistic regression analysis was conducted to identify the factors influencing the long-term efficacy of ultrasound-guided microwave ablation in patients with recurrent liver cancer. Results In the poor prognosis group, 8 cases (36.36%) of patients were classified as Child-Pugh grade B, 11 cases (50.00%) had multiple lesions, 10 cases (45.45%) had lesion diameter ≥3 cm, and 9 cases (40.91%) had AFP ≥100 ng/mL. In comparison, the good prognosis group had 8 cases (13.79%) with Child-Pugh grade B, 12 cases (20.69%) with multiple lesions, 13 cases (22.41%) with lesion diameter ≥3 cm, and 10 cases (17.24%) with AFP ≥100 ng/mL. These differences were found to be statistically significant (P＜0.05). Multivariate Logistic regression analysis further confirmed that Child-Pugh grade B, multiple lesions, lesion diameter ≥3 cm, and AFP≥100 ng/mL were identified as risk factors for a poor prognosis in patients with recurrent liver cancer after ultrasus-guided microwave ablation (P<0.05). Conclusion Ultrasound-guided microwave ablation has better long-term efficacy for patients with Child-Pugh grade A, single lesion, lesion diameter < 3 cm, and AFP < 100 ng/mL.

Key words: Ultrasonic guided microwave ablation, Recurrent liver cancer, Curative effect, Influencing factor

杨利平, 于杰, 李勤英, 夏艳, 齐高昂, 尚芮, 武龙君, 高磊. 超声引导下微波消融对复发性肝癌长期疗效的影响因素研究[J]. 肝脏, 2024, 29(2): 189-192.

YANG Li-ping, YU Jie, LI Qin-ying, XIA Yan, QI Gao-ang, SHANG Rui, WU Long-jun, GAO Lei. Study on the factors influencing the long-term efficacy of ultrasound-guided microwave ablation for recurrent liver cancer[J]. Chinese Hepatolgy, 2024, 29(2): 189-192.

参考文献

[1] Hu Y, Zeng S, Li L, et al. Risk factors associated with postoperative complications after liver cancer resection surgery in western China[J]. Cost Eff Resour Alloc,2021,19(1):64-64.
[2] Teng W N, Wu H L, Tai Y H, et al. Group-based trajectory analysis of postoperative pain and outcomes after liver cancer surgery[J]. J Chin Med Assoc,2021,84(1):95-100.
[3] Tsilimigras D I, Sahara K, Moris D, et al. Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers[J]. Ann Surg Oncol,2020,27(9):3318-3327.
[4] 李姗姗, 李开艳, 黄哲, 等. 特殊部位小肝癌超声引导下微波消融与手术切除的对比研究[J]. 介入放射学杂志, 2021, 30(8):784-787.
[5] 马思聪, 王涛, 丁敏, 等. 超声引导下微波消融一线治疗原发性肝癌:临床疗效以及预后影响因素[J]. 肝脏,2016,21(5):355-359.
[6] 王艳巧, 陈传杰, 张光文. 乙型肝炎相关性肝癌患者肝切除术后肿瘤复发的相关因素调查[J]. 肝脏,2020,25(8):885-888.
[7] 朱献忠, 张献南, 王琴, 等. 经导管肝动脉化疗栓塞术联合微波消融用于复发性肝癌的预后及其相关预测因素分析[J]. 中华全科医学,2021,19(2):227-231.
[8] 张波涛, 崔智飞, 段希斌, 等. 射频消融术和腹腔镜肝切除术治疗复发性肝癌的临床疗效及远期生存情况分析[J]. 癌症进展,2020,18(5):482-484,499.
[9] 凌俊, 万文武, 曾政, 等. 经肝动脉化疗栓塞术联合微波消融与重复肝切除术治疗复发性肝细胞癌的效果比较[J]. 临床肝胆病杂志,2022,38(9):2053-2060.
[10] 李红霞, 贺春娇, 杨延飞. CT引导下微波消融联合经导管动脉栓塞化疗术治疗原发性肝癌的临床疗效及对血清指标的影响[J]. 癌症进展,2021,19(21):2224-2228.
[11] 董姝英, 薛炜, 李登科, 等. 腹腔镜肝切除术与经皮射频消融术治疗原发性小肝癌的效果对比研究及其预后的影响因素分析[J]. 现代生物医学进展,2022,22(10):1980-1985.
[12] 张学政, 吴冬冰, 张学娟, 等. 术前肝功能储备预测肝癌手术患者预后价值的倾向性匹配研究[J]. 现代肿瘤医学,2022,30(24):4486-4490.
[13] 原强, 靳勇, 白旭明, 等. 经肝动脉化疗栓塞联合射频消融治疗原发性肝癌及术后复发性肝癌的疗效比较及预后因素分析[J]. 中国介入影像与治疗学,2016,13(3):146-150.
[14] 李长贤, 张慧, 吴晓峰, 等. 不同中国肝癌分期肝癌根治性切除术后的临床效果及预后因素分析[J]. 中华外科杂志,2021,59(2):134-143.
[15] 刘宜翔, 牛坚, 王梦, 等. 外周血白细胞介素-27及临床病理因素对肝癌微波消融后发生局部肿瘤进展的预测价值[J]. 国际外科学杂志,2020,47(2):92-97,封4.
[16] 贺娟, 肖伟利, 任志宏, 等. 血清AFP、CEA与肝癌患者临床病理分期和预后的关系及其诊断价值分析[J]. 现代生物医学进展,2020,20(8):1501-1505.
[17] 邓海燕, 阮琳玲, 杨晓冬, 等. PAB、FER、AFP及其异质体在原发性肝癌鉴别诊断及肿瘤分期中的应用价值[J]. 重庆医学,2021,50(21):3702-3705.
[18] 赵灵利, 王磊, 张裕, 等. 血清γ-谷氨酰转肽酶及甲胎蛋白对肝动脉化疗栓塞术治疗原发性肝癌患者预后的影响[J]. 临床误诊误治,2022,35(6):59-63.